Skip to main content

Penumbral Rescue by Normobaric O=O Administration in Patients With Ischaemic Stroke and Target Mismatch ProFile: A Phase II Proof-of-Concept Trial

Ziel

Ischemic stroke (IS), caused by occlusion of arteries that supply blood to the brain, remains a leading cause of mortality and morbidity in the world. Disruption of blood and oxygen supply to the brain leads to neuronal death in the ischemic core within minutes. The hypoperfused tissue surrounding the ischemic core, the penumbra, is at high risk for infarction over time but still salvageable. Neuroprotective “bridging”, sustaining the penumbra until reperfusion, may widen the therapeutic window, make recanalization treatments accessible to more patients and improve overall IS outcomes.
As ischemic cell death is primarily mediated by hypoxia, increasing oxygen supply to the penumbra seems THE logical approach. In animal models of IS, normobaric hyperoxygenation (NBHO) significantly increased penumbral oxygen pressure and attenuated brain injury when initiated early after onset of ischaemia and vessel occlusion was transient (35 to 50% infarct volume reduction).
The PROOF project now seeks to demonstrate that NBHO (high-flow 100% oxygen at >45 L/min via a non-rebreather mask, or FiO2=1.0 for intubation/ventilation) reduces infarct growth from baseline to 24 hours compared to standard treatment if administered ≤3 hours after onset of anterior circulation IS, in patients with proximal vessel occlusion and salvageable tissue at risk. The study is multi-center, adaptive phase-IIb, randomized, open-label with blinded-endpoint (PROBE design).
The primary efficacy criterion will be infarct growth from baseline to 24 hours. Secondary endpoints will be NIHSS 24h, categorical shift in the pre-stroke modified Rankin Score, QoL and cognition at day 90.
Potential surrogate biomarkers, health economics and societal impacts will be assessed.
If NBHO proves its neuroprotective potential in this selected population, phase-III trials in all IS patients may be undertaken. Considering its low costs and ease of use, NBHO may impact stroke care worldwide.

Aufforderung zur Vorschlagseinreichung

H2020-SC1-2016-RTD
Andere Projekte für diesen Aufruf anzeigen

Koordinator

EBERHARD KARLS UNIVERSITAET TUEBINGEN
Adresse
Geschwister-scholl-platz
72074 Tuebingen
Deutschland
Aktivitätstyp
Higher or Secondary Education Establishments
EU-Beitrag
€ 1 498 742,74

Beteiligte (11)

KATHOLIEKE UNIVERSITEIT LEUVEN
Belgien
EU-Beitrag
€ 321 625
Adresse
Oude Markt 13
3000 Leuven
Aktivitätstyp
Higher or Secondary Education Establishments
FAKULTNI NEMOCNICE U SV. ANNY V BRNE
Tschechien
EU-Beitrag
€ 118 650
Adresse
Pekarska 53
656 91 Brno
Aktivitätstyp
Higher or Secondary Education Establishments
HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMÄ
Finnland
EU-Beitrag
€ 137 463
Adresse
Stenbackinkatu 9
00029 Helsinki
Aktivitätstyp
Research Organisations
GROUPE HOSPITALIER UNIVERSITAIRE PARIS PSYCHIATRIE ET NEUROSCIENCES
Frankreich
EU-Beitrag
€ 246 814
Adresse
Rue Cabanis 1
75014 Paris
Aktivitätstyp
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA
Spanien
EU-Beitrag
€ 715 274,50
Adresse
Passeig Vall D Hebron 119-129 Edificio De Recerca
08035 Barcelona
Aktivitätstyp
Research Organisations
VÄSTRA GÖTALANDSREGIONEN
Schweden
EU-Beitrag
€ 185 600
Adresse
Regionens Hus
462 80 Vanersborg
Aktivitätstyp
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS
Schweiz
EU-Beitrag
€ 26 225
Adresse
Rue Du Bugnon 21
1011 Lausanne
Aktivitätstyp
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
EPPDATA GMBH
Deutschland
EU-Beitrag
€ 737 875
Adresse
Mehlbeerweg 10
22391 Hamburg
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
STROKE ALLIANCE FOR EUROPE
Belgien
EU-Beitrag
€ 66 625
Adresse
Rue Washington 40
1050 Brussels
Aktivitätstyp
Other
UNIVERSITATSKLINIKUM HEIDELBERG
Deutschland
EU-Beitrag
€ 1 350 776,25
Adresse
Im Neuenheimer Feld 672
69120 Heidelberg
Aktivitätstyp
Higher or Secondary Education Establishments
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK
Frankreich
EU-Beitrag
€ 373 157
Adresse
5 Rue Watt
75013 Paris
Aktivitätstyp
Research Organisations